Our Phase II & III Capabilities

Many of our sites have participated in research for 10+ years. Our partnerships provide access to CA residents throughout the State with nearly 20 partnerships in over 50+ locations. We help provide access to a diverse patient population, including minority groups that otherwise go unrepresented in research. 

Rapid Start

Capabilities

Quality Control

Our Diverse Data

Race/Ethnicity

US Census (%)

(2019)

US Patients (%) in Clinical Trials

FOMAT Enrollment

(%)

White / Caucasian

76.5

84.2

36%

Black/African-American

13.4

7.3

1%

Asian

5.9

3.4

5%

Native Hawaiian/ Pacific Islander

0.2

0.1

0.3%

Native-Indian/Native Alaskan

1.3

0.1

0.3%

More than 1 race

2.7

0.0

3%

Other/Unknown

-

3.7

7.4%

Hispanic/Latino

18.3

2.8

47%